78 /100
CRITICAL RISK
Score updated May 29, 2026

OLB — The OLB Group, Inc. Dilution Risk Tracker

Track OLB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track OLB — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
100
💰 Cash Runway
85
📊 Float Risk
52
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
65%
💰 Capital Raise 73%
• Low cash runway: 5 months remaining
• Active shelf registration ($1000M, 15533% of market cap)
🔄 Reverse Split 70%
• 50-day avg $0.49 below $1 exchange minimum
• Only 5 months cash — financial pressure
🔁 Convertible Conversion 40%
• Significant convertible debt: 25% potential dilution
• Elevated convertible risk (60/100)
🔔 Track OLB — Get forecast alerts →

💹 Market Data

Market Cap$6.44M
Shares Outstanding14.66M
Float7.98M
Cash$2.33M
Debt$334.5K
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 83.6% shares (2025Q4 vs prior)
15 institutional holders · 279.5K shares
#1 CITADEL ADVISORS LLC 126.4K shares
#2 Avalon Trust Co 36.0K shares
#3 XTX Topco Ltd 27.6K shares
+ 12 more holders Sign up free to view →

📉 Short Interest

Short Interest630.8K
Days to Cover1.4
% of Float7.9%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Feb 18, 2026
xbrl XBRL CONVERTIBLE Sep 30, 2024
EFFECT EFFECT Apr 28, 2026
S-1 SHELF Apr 16, 2026
8-K 8K EVENT Feb 23, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track OLB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking OLB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for OLB
📊 OLB FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 OLB Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.